ST
Sarepta Therapeutics Inc
🇺🇸XNAS.SRPTUnited StatesHealthcare
$19.76USDdown -0.93 (-4.49%)ClosedDelayed1:49 AM
Price$19.76-0.93 (-4.49%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US8036071004
- CUSIP
- 037184108
Company
- Employees
- 835
- Headquarters
- Cambridge, United States
- Website
- https://www.sarepta.com
- CEO
- Dr. Michael E. Severino M.D.
Market
- Shares outstanding
- 105.6M
- Market cap
- $2.09B
Key dates
- Next earnings
- Nov 2, 2026
Highlights
- Market cap
- $2.19B
- EPS LTM
- -$1.29calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -15.27calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.97B-20.44%down year on year
- Net income
- -$136.73M-135.91%down year on year
- Gross margin
- 58.56%-26.14%down year on year
- Free cash flow
- -$131.47M+71.04%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.